James E Flynn, a major owner of Acutus Medical, Inc. and a director of the company, recently acquired 1,800 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on June 17, 2021. Flynn now owns 4,022 shares of the company. Flynn operates out of New York, NY. Some additional info was provided as follows:
The reported shares of Common Stock are issuable upon settlement of a restricted stock unit ("RSU"). The RSU is scheduled to vest as to all of the shares of Common Stock subject to the RSU on the first anniversary of the date of grant of such RSU, if on such date Andrew ElBardissi has remained in continuous service as a director.
Andrew ElBardissi, a partner in Deerfield Management
Company, L.P. ("Deerfield Management"), serves as a director of the Issuer. The RSU and the option granted to Mr. ElBardissi and reported herein are held for the benefit, and at the direction, of Deerfield Management.
The option was granted to Mr. ElBardissi on June 17, 2021 and is scheduled to vest and become exercisable as to all of the shares of Common Stock underlying such option on the first anniversary of the date of grant of such option, if on such date the Andrew ElBardissi has remained in continuous service as a director.
This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Acutus Medical, Inc. makes a similar move, sign up!
